VIKAS KUNDRA to Bone Neoplasms
This is a "connection" page, showing publications VIKAS KUNDRA has written about Bone Neoplasms.
Connection Strength
0.492
-
In vivo imaging of prostate cancer involving bone in a mouse model. Prostate. 2007 Jan 01; 67(1):50-60.
Score: 0.120
-
Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate Cancer. Eur Urol Oncol. 2022 04; 5(2):164-175.
Score: 0.084
-
Bempegaldesleukin (BEMPEG; NKTR-214) efficacy as a single agent and in combination with checkpoint-inhibitor therapy in mouse models of osteosarcoma. Int J Cancer. 2021 04 15; 148(8):1928-1937.
Score: 0.078
-
Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases. Sci Transl Med. 2014 Sep 03; 6(252):252ra122.
Score: 0.051
-
Conspicuity of bone metastases on fast Dixon-based multisequence whole-body MRI: clinical utility per sequence. Magn Reson Imaging. 2013 Jun; 31(5):669-75.
Score: 0.045
-
Fast Dixon whole-body MRI for detecting distant cancer metastasis: a preliminary clinical study. J Magn Reson Imaging. 2012 Feb; 35(2):399-408.
Score: 0.042
-
Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms. J Clin Invest. 2008 Aug; 118(8):2697-710.
Score: 0.033
-
Prostate cancer imaging. Semin Roentgenol. 2006 Apr; 41(2):139-49.
Score: 0.028
-
Effect of transforming growth factor beta (TGF-?) receptor I kinase inhibitor on prostate cancer bone growth. Bone. 2012 Mar; 50(3):695-703.
Score: 0.011